Table 2.
Distribution of newborns and infants in age categories
| Drugs (n) | ≥ 42 weeks PMA (n) | 37 to < 42 weeks PMA (n) | < 37 weeks PMA (n) | PNA (days) | GA (weeks) | PMA (weeks) | Body weight (kg) | SCR (mg/dL) |
|---|---|---|---|---|---|---|---|---|
| Amikacin (108) | 22 | 11 | 75 | 10 (3–625) | 29 (23–41) | 31 (25–127) | 1.29 (0.45–11.28) | 0.38 (0.2–0.96) |
| Gadobutrol (43) | 39 | 4 | 0 | 212 (6–696) | 40 (40–40) | 70 (41–139) | 7.2 (2.80–14.20) | 0.27 (0.1–0.66) |
| Gadoterate (45) | 41 | 4 | 0 | 266 (4–721) | 40 | 78 (39–143) | 8.00 (3.00–15.00) | 0.24 (0.14–0.42) |
| Vancomycin (92) | 22 | 31 | 39 | 13 (2–367) | 36 (24–41) | 39 (25–89) | 2.61 (0.53–8.26) | 0.5 (0.18–1.67) |
| Ampicillin (73) | 5 | 31 | 37 | 2 (0–24) | 36 (24–41) | 37 (25–43) | 2.47 (0.50–4.19) | 0.6 (0.2–2.5) |
| Gentamicin (143) | 46 | 48 | 49 | 1 (0–711) | 37 (23–43) | 38 (23–135) | 3.12 (0.40–12.00) | 0.6 (0.18–5.5) |
| Meropenem (200) | 13 | 31 | 156 | 21 (1–92) | 28 (23–40) | 32 (24–51) | 1.54 (0.39–6.50) | 0.5 (0.1–1.9) |
| Netilmicin (83) | 1 | 3 | 79 | 10 (2–121) | 27 (23–41) | 29 (24–43) | 1.00 (0.47–3.00) | 0.77 (0.27–1.67) |
| All drugs (787) | 189 | 163 | 435 | 13 (0–721) | 33 (23–43) | 35 (23–143) | 2.16 (0.39–15.00) | 0.5 (0.1–5.5) |
GA, gestational age; PMA, postmenstrual age; PNA, postnatal age; SCR, serum creatinine.